Loading...
Loading...
NPCE| Name | Value |
|---|---|
| Revenues | 19.3M |
| Cost of Revenue | 5.1M |
| Gross Profit | 14.1M |
| Operating Expense | 20.4M |
| Operating I/L | -6.2M |
| Other Income/Expense | -1.3M |
| Interest Income | 0.8M |
| Pretax | -7.5M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -7.5M |
NeuroPace, Inc. is a US-based medical device company specializing in the development and sale of the RNS system, a brain-responsive neuromodulation system designed to treat medically refractory focal epilepsy. The RNS system delivers personalized real-time treatment at the seizure source and records continuous brain activity data, allowing clinicians to monitor patients in person and remotely. The company generates revenue by selling its RNS system to hospital facilities for initial implant procedures and replacements, providing a vital solution for patients with epilepsy that is not responsive to medication.
